Shiga Microalbuminuria Reduction Trial-2

NCT01461499 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

237

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Hypertension

Interventions

DRUG: Aliskiren
DRUG: any angiotensin receptor blockers

Sponsor

Shiga University